Focai Bio ("FOE-sigh”) provides scalable single-cell drug distribution measurements of radiopharmaceuticals in tissue sections and spatially aware models using patent-pending technologies.
What is the problem?
Poor drug efficacy and clinical trial failures are frequently caused by incomplete drug distribution within a tissue, but this is only identified after hundreds of millions of dollars have been spent. With molecular targeting now easily designed, the critical gap is designing drugs that reach effective doses everywhere they are needed.
What is their solution?
Focai Bio provides single-cell drug distribution measurements of radiopharmaceuticals to simultaneously quantify drug and target distribution in high-dimension molecular readouts within organized tissues at the scale needed to train foundation models to predict drug distribution.
